loading net worth // from filings
albert bourla net worth // filing-anchoredas of 2026-02-25 · Form 4
Albert Bourla Net Worth (2026)
Albert Bourla is Chairman & CEO of Pfizer (PFE). Most of a public-company CEO’s on-paper wealth is their stake in that company — anchored here on the number you can verify.
WHAT WE ESTIMATE
varies
Past cash compensation, sold shares, real estate, and other public holdings — estimable from records, but not exact.
WHAT CAN’T BE KNOWN
private
Private company stakes, trusts, cash, debts, and undisclosed assets. Anyone publishing these as a single number is guessing.
At a glance
| Company | Pfizer (PFE) |
| Title | Chairman & CEO |
| Verified stake | $10M |
| Shares owned | 394,674 |
| Latest total pay | $28M breakdown → |
| Age | ~65 |
HOW THIS IS CALCULATED
We take the shares Albert Bourla reports owning in their most recent SEC Form 4 and multiply by the latest share price. That gives a stake value you can check against the filing itself. Everything beyond that stake — real estate, private holdings, cash, past compensation — is estimated or simply not public, and we say so rather than roll it into one number.
BIOGRAPHY
Albert Bourla was born in Thessaloniki, Greece, in 1961, into a Sephardic Jewish family who survived the Holocaust that destroyed most of the city’s Jewish community. He trained as a veterinarian and earned a doctorate in the biotechnology of reproduction from Aristotle University, and joined Pfizer in 1993 in its animal-health business in Greece.
He spent a quarter century climbing through the company across continents and divisions before becoming chief operating officer and then, in 2019, chief executive. Within a year he made the defining bet of his tenure, backing the crash program that produced the Pfizer-BioNTech COVID-19 vaccine.
Bourla is a hired executive who joined mid-career. His Pfizer stake came from accumulated stock compensation, which is what this page reflects.
Born 1961 · Aristotle University of Thessaloniki (DVM; PhD, Reproductive Biotechnology)
CAREER
NOTABLE
- Won the 2022 Genesis Prize and donated the million-dollar award to Holocaust education.
- Wrote Moonshot, an account of Pfizer COVID-vaccine race, and led major acquisitions including Seagen.
COMPENSATION HISTORY · from SEC proxy statements
| Fiscal year | Total pay |
|---|---|
| 2025 | $28M |
| 2024 | $25M |
The richest CEOs
Ranked by filing-verified stake
The stake value is filing-derived and verifiable; any broader “net worth” is an estimate. Photo: World Economic Forum, CC BY 3.0 (Wikimedia Commons). Share counts are the latest reported on SEC filings and change as the executive trades; the price is the last close, so the stake value moves with the market. This is not an official or complete accounting of anyone’s wealth. Educational only — not investment advice.
